February 18, 2022
Recipharm acquires Vibalogics and Arranta Bio
Recipharm, a global contract development and manufacturing organisation (CDMO), has announced the acquisition of Vibalogics, a virotherapy CDMO and a…
Pharmaceuticals, Biotechnology and Life Sciences
Tag: Vibalogics
May 9, 2019
Vibalogics increases capacity with a new 200L line for virus manufacturing
GERMANY-based contract development and manufacturing organization (CDMO) Vibalogics has increased its single-use bioreactor and purification capacity with a new manufacturing line to meet increasing demand for its specialist oncolytic virus and viral vector manufacturing services.